Jennison Associates LLC / BMRN
Jennison Associates LLC’s Biomarin Pharmaceutical Inc Position
Does Jennison Associates LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 332.0K shares worth $32M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$32M
Q4 2023
Shares
332.0K
% of Portfolio
+0.02%
Quarters Held
18
position exited
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 332.0K | $32M | +0.02% |
| Q3 2023 | 589.3K | $52M | +0.04% |
| Q2 2023 | 177.8K | $15M | +0.01% |
| Q1 2023 | 674.1K | $66M | +0.06% |
| Q4 2022 | 578.6K | $60M | +0.06% |
| Q3 2022 | 563.5K | $48M | +0.05% |
| Q2 2022 | 729.2K | $60M | +0.06% |
| Q1 2022 | 706.5K | $54M | +0.04% |
| Q4 2021 | 552.5K | $49M | +0.03% |
| Q4 2020 | 454.0K | $40M | +0.03% |
| Q3 2020 | 652.8K | $50M | +0.04% |
| Q2 2020 | 7.59M | $936M | +0.85% |
| Q1 2020 | 8.21M | $694M | +0.84% |
| Q4 2019 | 7.04M | $595M | +0.60% |
| Q3 2019 | 8.33M | $562M | +0.59% |
| Q2 2019 | 9.45M | $809M | +0.80% |
| Q1 2019 | 12.41M | $1.1B | +1.10% |
| Q4 2018 | 11.60M | $988M | +1.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jennison Associates LLC’s full portfolio or all institutional holders of BMRN.